Rep. Pallone: Bipartisan E&C Leaders Request FDA Briefing on Threat to U.S. Heparin Supply
July 30, 2019
July 30, 2019
WASHINGTON, July 30 -- Rep. Frank Pallone Jr., D-New Jersey, chairman of the House Energy and Commerce Committee, issued the following news release:
Energy and Commerce Committee leaders sent a letter (https://energycommerce.house.gov/sites/democrats.energycommerce.house.gov/files/documents/FDA.2019.7.30..pdf) to Food and Drug Administration (FDA) Acting Commissioner Dr. Norman E. "Ned" Sharpless requesting briefings on the potential threat to the U.S. supply of heparin, t . . .
Energy and Commerce Committee leaders sent a letter (https://energycommerce.house.gov/sites/democrats.energycommerce.house.gov/files/documents/FDA.2019.7.30..pdf) to Food and Drug Administration (FDA) Acting Commissioner Dr. Norman E. "Ned" Sharpless requesting briefings on the potential threat to the U.S. supply of heparin, t . . .